Paydirt
MS
Insider

Mark Douglas Smith

Director

Mark Douglas Smith (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $267K of JAZZ (1,157 sh × $230.55, as filed), executed Jun 15.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$267K
shares × price, as filed
Last traded
Jun 15
Filed Jun 17

Median ADV $110.0M across their filed names

Open performance
Volume by month
$267K$133K$0Oct 2024Apr 2025Oct 2025Apr 2026Jul 2025 · sells $203KJun 2026 · sells $267K
Buys $0 Sells $470K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
JAZZ Jazz Pharmaceuticals plc JAZZ · 0 buys · 1 sell 1 filing PHR Phreesia, Inc. PHR · 0 buys · 1 sell 1 filing
Recent filings
JAZZSALE Jazz Pharmaceuticals plc View filing → $267K
1,157 sh × $230.55
Exec Jun 15
Filed Jun 17 · 5:30 PM ET
PHRSALE Phreesia, Inc. View filing → $203K
7,000 sh × $29.00
Exec Jul 2 2025
Filed Jul 3 2025 · 5:30 PM ET